TrialDrugs in R&D2025

Bioequivalence of Two Perampanel Oral Suspension Formulations in Healthy Subjects: A Randomized Crossover Study.

Aya M AbdelMagid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.